SINOVAC BIOTECH LTD

SVA ·Healthcare, Drug Manufacturers - General
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $84.2M
Cost of Revenue $20.1M
Gross Profit $64.1M
Gross Margin 76.2%
Operating Expenses
Research & Development $4.4M
SG&A Expense $18.2M
Operating Income $42.1M
Operating Margin 50.1%
Interest Expense —
Pretax Income $41.6M
Income Tax Expense $11.1M
Net Income $20.0M
Net Margin 23.7%
EPS (Basic) $0.47
EPS (Diluted) $0.46
Shares Outstanding (Basic) 42.6M
Shares Outstanding (Diluted) 43.0M
Dividends Per Share —
← Newer Page 3 of 3 Older →